Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992–2015

Details

• Alternative Title:
  Vaccine
• Personal Author:
  Childs, Lana ; Roesel, Sigrun ; Tohme, Rania A.
• Description:
  In 2016, the Immunization Technical Advisory Group of the South-East Asia Region (SEAR) endorsed a regional goal to achieve ≤1% prevalence of hepatitis B surface antigen (HBsAg) among 5-year-old children by 2020. Chronic hepatitis B virus (HBV) infection is largely preventable with a birth dose of hepatitis B vaccine (HepB-BD) followed by two to three additional doses. We reviewed the progress towards hepatitis B control through vaccination in SEAR during 1992-2015. We summarized hepatitis B vaccination data and reviewed the literature to determine the prevalence of chronic HBV infection pre- and post-vaccine introduction. We used a mathematical model to determine post-vaccine prevalence of HBsAg among 5 year olds in countries lacking national serosurvey data and estimated the impact of vaccination on disease burden. Regional coverage with three doses of hepatitis B vaccine (HepB3) increased from 56% in 2011 to 87% in 2015. By 2016, 7 of 11 countries had introduced universal HepB-BD. Regional HepB-BD coverage increased from 9% in 2011 to 34% in 2015. In 2015, estimated HBsAg among 5 year olds was 1.1% with variability among countries. Myanmar (3.8%), Timor-Leste (2.7%), Indonesia (1.8%), and India (1%) had the highest prevalence of HBsAg. During 1992-2015, vaccination prevented approximately 16 million chronic HBV infections and 2.6 million related deaths. In 2015, around 197,640 perinatal HBV infections occurred in SEAR with majority occurring in India (62%), Bangladesh (24%), and Myanmar (8%). Myanmar had the highest rate of perinatal chronic HBV infections at 16 per 1000 live births. Despite significant progress in the control of HBV, SEAR needs to secure political commitment for elimination and consider additional strategies, such as promoting health facility births, universal birth dose administration, developing strong coordination between health sectors, and using alternative vaccine delivery methods, to improve HepB-BD coverage and subsequently achieve HBV control and elimination.
• Subjects:
  Adolescent Adult Article Asia, Southeastern Child Child, Preschool Communicable Disease Control Female Health Facilities Hepatitis B Hepatitis B, Chronic Hepatitis B Antibodies Hepatitis B Surface Antigens Hepatitis B Vaccine Hepatitis B Vaccines Hepatitis B Virus Humans Immunisation Immunization Programs Infant, Newborn Male Pregnancy Prevalence Southeastern Asia Vaccination Young Adult

  More +
• Source:
  Vaccine. 36(1):6-14
• Pubmed ID:
  29174317
• Pubmed Central ID:
  PMC5774012
• Document Type:
  Journal Article
• Funding:
  001/WHO_/World Health OrganizationInternational/ ; CC999999/ImCDC/Intramural CDC HHSUnited States/
• Volume:
  36
• Issue:
  1
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:8b0a7061ca6ca49c74e0c31d27ccd572d75737c5dc4a2f43d4adc0416655a783
• Download URL:
  https://stacks.cdc.gov/view/cdc/51043/cdc_51043_DS1.pdf
• File Type:
  [PDF - 817.39 KB ]